Related Experiment Video
Updated: Jun 1, 2026
09:01
Chronic Salmonella Infected Mouse Model
Published on: May 31, 2010
Humanized mice for Salmonella typhi infection: new tools for an old problem
M Firoz Mian1, Elisabeth A Pek, Meghan J Chenoweth
1Department of Pathology and Molecular Medicine, Center for Gene Therapeutics and Institute for Infectious Disease Research, McMaster University, Hamilton, ON, Canada.
Virulence
|May 31, 2011
Summary
A new humanized immune system (HIS) mouse model effectively mimics human typhoid fever. This breakthrough advances Salmonella Typhi research, aiding the development of novel antimicrobials and vaccines against resistant strains.
Area of Science:
- Infectious Diseases
- Immunology
- Microbiology
Background:
- Salmonella enterica serovar Typhi (S. typhi) causes typhoid fever, a significant global health concern.
- Multidrug-resistant S. typhi strains are increasing, necessitating new research avenues.
- Previous research was limited by the lack of animal models that accurately reflect human typhoid fever's immunology.
Purpose of the Study:
- To develop a suitable animal model for studying Salmonella Typhi infections.
- To investigate the immunological features of human typhoid fever in a preclinical setting.
- To facilitate the discovery of new treatments for typhoid fever.
Main Methods:
- Development of a humanized immune system (HIS) mouse model.
- Intravenous challenge of the HIS mouse model with S. typhi.
- Observation and analysis of disease manifestations, including pathology and mortality.
Main Results:
- The HIS mouse model displayed classical human typhoid fever symptoms, including meningitis and liver pathology.
- The model exhibited mortality consistent with severe S. typhi infections.
- Concurrent development of similar models by other research groups validates this approach.
Conclusions:
- The developed HIS mouse model provides a valuable platform for studying S. typhi.
- This model is crucial for understanding the cellular and molecular mechanisms of typhoid fever.
- It promises to accelerate the development of effective antimicrobials and vaccines against S. typhi infections.
